Skip to main content
Clinical Trials/ACTRN12618000984291
ACTRN12618000984291
Not yet recruiting
Phase 4

Efficacy of Sub-dermal Injection of Triamcinolone Acetonide for Treatment of Caesarean Section Keloid Scars

Westmead hospital0 sites150 target enrollmentStarted: June 12, 2018Last updated:

Overview

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Westmead hospital
Enrollment
150

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 45 Years (—)
Sex
Female

Inclusion Criteria

  • 1\. Presence of a keloid scar from a previous caesarean section
  • 2\. Planed caesarean section for this current pregnancy

Exclusion Criteria

  • 1\.Primigravida
  • 2\.Previous caesarean section without keloid scar

Investigators

Sponsor
Westmead hospital

Similar Trials